Navigation Links
University of Maryland Company Trauma Solutions Named Finalist in $250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition
Date:6/25/2009

COLLEGE PARK, Md., June 25 /PRNewswire-USNewswire/ -- Trauma Solutions, a company developing the first and only synthetic, hemostatic material capable of simultaneously inducing blood clotting and delivering therapeutics, has been named a finalist in the $250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition.

The company, founded by graduate research assistant Brendan Casey and Keystone Professor Peter Kofinas, both from the Fischell Department of Bioengineering, along with Adam Behrens, an undergraduate research assistant from the Department of Chemical and Biomolecular Engineering, is one of 16 finalists from fifteen different schools in six countries. Finalists were selected from thousands of eligible business plans in nine countries across the globe.

Trauma Solutions, formerly called Haemechanics, took first place and $20K in the University of Maryland $75K Business Plan Competition in the life sciences division on May 8.

"We are very excited to be selected as finalists for this prestigious international business plan competition," says Kofinas. "This will result in higher visibility for our hemostatic product and an opportunity to network with one of the nation's premier venture capital firms and a technology industry leader. We are grateful to Jim Chung, director of the Mtech VentureAccelerator program, for his help and coaching."

Trauma Solutions' hemostatic (stops bleeding) material is able to induce clotting as effectively as biologically based products at a fraction of the price. Its capability to simultaneously deliver therapeutics in a regulated manner makes it completely unique to the market and in line with the specific demands of commercial, next generation hemostatics and military-grade blood coagulation materials for use on the battlefield. Trauma Solutions was founded to develop an advanced line of hemostatic products based on this material.

Finalists for the Draper Fisher Jurvetson and Cisco Systems Competition will compete from their respective geographic areas via Cisco TelePresence(TM) on June 30. The winning team will receive a minimum seed investment of $250,000.

"The selection of Trauma Solutions as a finalist for this competition only corroborates and reinforces the qualities that judges saw in the company just last month when it walked away with a first place prize in our own rigorous competition," says Dean Chang, director of the Maryland Technology Enterprise Institute's ventures and education programs. "Trauma Solutions is yet another example of the importance of university venture creation resources and programs like those at the University of Maryland that act as launch points for promising technologies with genuine potential to address billion dollar needs and pain points in our society."

Finalist selection was based on various criteria including quality of management team, technical innovation, addressable market size, competitive positioning, barriers, capital efficiency, and financial projections. Most finalists are still in the early stages of business development. In addition to the financial investment awarded to the winner, both DFJ and Cisco will assist the winner and finalists in leading the next wave of disruptive technologies by providing mentorship and professional assessments regarding their submissions.

"Clearly global innovation doesn't stop for recessions," says Tim Draper, managing director, DFJ. "These promising candidates are reminding us that there are pioneering companies out there, even in difficult times, and we hope that one of these teams creates the next Skype, Google, Facebook, Baidu or Cisco. This competition fosters a culture of entrepreneurship that has a lasting impact, and its benefits are felt not just by the winning team but by all participants. We look forward to continuing meaningful ties with all of these young entrepreneurs in the future."

Competitors and the media will be invited to view the competition via simulcast beginning at 8 a.m. PDT on June 30, and the winner will be announced at 6:30 p.m. PDT the same day.

About the Maryland Technology Enterprise Institute (Mtech) www.mtech.umd.edu

The mission of the Maryland Technology Enterprise Institute (Mtech) is tri-fold: educate the next generation of technology entrepreneurs; help entrepreneurs create successful technology-based ventures; and connect Maryland companies with university resources to help them succeed. Founded in 1983, Mtech has had a $19.6 billion cumulative impact on the Maryland economy through its programs. Mtech is a unit of the A. James Clark School of Engineering at the University of Maryland.


'/>"/>
SOURCE University of Maryland
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University of Leeds wins $18 million funding to improve the quality of our old age
2. Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine
3. Veran Medical Enables Breakthrough 4D Navigation to Cancer Lesions at University of Virginia Hospital
4. Morning People and Night Owls Show Different Brain Function: University of Alberta Study
5. McGill University receives almost $63 million under CFI program to support 5 research projects
6. AACR CEO Margaret Foti receives honorary M.D. from the University of San Pablo CEU
7. Herzing University, Minneapolis Receives Board of Nursing Approval
8. Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem
9. Hebrew University research leads to advanced trials of new cancer treatment
10. Western Governors University Offers Special Nursing Scholarships for Employees of Hospital Partners
11. University HealthSystem Consortium Selected as Greenville Hospital Systems Supply Chain Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... Drs. Gregory ... hygiene symposium in Mystic, CT. Covering the process and maintenance strategies of gum ... these popular periodontal procedures. Drs. Toback and Urbanski practice as experienced periodontists ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... . Orthodontics is a dental specialty that focuses on treating alignment and occlusion ... improved aesthetics and function. , North Hollywood dentist , Dr. Garemani, ...
(Date:6/26/2017)... ... ... Center is now offering various types of dental implants to restore lost teeth. Dental implants ... such as crowns, bridges, or dentures. An implant is placed directly into the jawbone where ... tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... Ruidoso, New Mexico (PRWEB) , ... June 26, ... ... sexual dysfunction, anorgasmia, and urinary leakage is revolutionizing the way women look and ... Mexico is tackling the problem of female sexual dysfunction and urinary leakage head ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... New patients ... from Dr. Angela Cotey, with or without a referral. Dr. Cotey is a trusted ... of this preferred tooth replacement option. , Patients with missing teeth in Fitchburg, WI, ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: